Why Signing Up?
  • Early Access to Unparalleled Data: Get a first look at structured toxicological data on 530 approved pharmaceuticals, spanning multiple study types such as repeat-dose toxicity, carcinogenicity, developmental toxicity, and reproductive toxicity.
  • Benefit of organized US FDA's Original Data with the Structure of ECHA’s IUCLID database: Our soon-to-be-enhanced dashboard, harnessing invaluable data from the US FDA and the support of the European Chemicals Agency (ECHA), promises accurate correlation and concordance analyses by effectively integrating both animal and human data.
  • Push the Boundaries of Toxicological Research: With our upcoming updates, you can harness the dashboard to develop advanced predictive toxicological models, including QSARs. Whether you're aiming to revolutionize industrial chemical regulatory systems or accurately predict pharmaceutical attrition rates, our tool will be indispensable.
  • Stay Updated & Ahead: As we finalize our enhancements, registered users will be the first to know. From early adverse reaction detection to preventing clinical trial failures, we're committed to supporting your research journey.
  • Respect for Your Time: We value your trust. Thus, we'll send no more than one email per month, ensuring only the most relevant and impactful updates reach you.
Discover More: Evangelisti et al. A non-clinical and clinical IUCLID database for 530 pharmaceuticals (part I): Methodological aspects of its development. Regulatory Toxicology and Pharmacology, 2023. Read the study.

Sign Up

Create your account today

https://toxicity-dataviz.innovamol.com/public/ https://toxicity-dataviz.innovamol.com//